Crestline Management, LP Portfolio Holdings

Crestline Management, LP

  • $62.6 Billion
  • Q2 2025

Crestline Management, LP has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $62.6 Billion distributed in 3 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Denali Therapeutics Inc. with a value of $54B, Sana Biotechnology, Inc. with a value of $6.61B, and 8 X8 Inc with a value of $1.94B.

Examining the 13F form we can see an decrease of $673M in the current position value, from $63.2B to 62.6B.

Crestline Management, LP is based out at Fort Worth, TX

Below you can find more details about Crestline Management, LP portfolio as well as his latest detailed transactions.

Portfolio value $62.6 Billion
Healthcare: $60.6 Billion
Technology: $1.94 Billion

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$1.77B
$54 Billion 86.33% of portfolio
3,860,732
Q2 2025 Reduced 7.21%
$592M
$6.61 Billion 10.56% of portfolio
2,420,937
Q2 2025 Reduced 13.26%
$202M
$1.94 Billion 3.1% of portfolio
990,580
Q1 2025 Reduced 0.78%

Summary

  • Portfolio
  • No. of Stocks 3
  • Current Value $62.6 Billion
  • Prior Value $63.2 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 2 stocks
Track This Portfolio

Track Crestline Management, LP Portfolio

Follow Crestline Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crestline Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Crestline Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email